
About the dean
Terence R. Flotte, MD, is provost, dean and executive deputy chancellor of UMass Chan Medical School, the only public medical school in Massachusetts. Since joining UMass Chan in 2007, Dr. Flotte has forged a path of unprecedented growth and achievement for the research, education and academic missions of the campus. An internationally known scientist, Flotte has conducted research on cutting edge molecular therapeutics that led to the first successful gene transfer with adeno-associated virus (AAV) in animals and the first ever human trial of an AAV. He also led the first human recombinant AAV trials in alpha-1 antitrypsin deficiency and Tay-Sachs disease, with the latter showing promising clinical benefits. He is the author of more than 280 scholarly papers and his research has been funded by the National Institutes of Health and the Alpha One Foundation. Since 2015, Flotte has also been editor-in-chief of gene therapy’s oldest journal family, Human Gene Therapy.
News articles
-
Read more
-
Chancellor Collins’ final Convocation address encourages optimism, determination
Read more -
UMass Chan celebrates start of academic year with Convocation Week 2025
Read more -
Phase I/II clinical study of gene therapy for GM2 gangliosidosis, including Tay-Sachs and Sandhoff diseases, shows encouraging results
Read more -
Gov. Healey’s DRIVE initiative aims to infuse $400M into state’s research and innovation economy
Read more -
UMass Chan celebrates naming of Paul J. DiMare Center
Read more -
Highly accomplished faculty named to endowed chairs
Read more -
‘A hope-filled moment’: UMass Chan celebrates Class of 2025
Read more -
T.H. Chan School of Medicine Class of 2025 celebrated at annual breakfast
Read more